4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-22-007687
CHIEF MEDICAL OFFICER acquired 5,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Mark Alan CHIEF MEDICAL OFFICER | 2022-06-30 | Grant or award | +5,000 | $0.75 | $3,740 | 19,915 | D |
Loading xslF345X03/form4-07152022_040709.xml…